Fintech

Matricelf (TASE: MTLF) Enters Strategic Collaboration with Sheba Medical Center to Advance First in Human Clinical Program in Spinal Cord Injury

Prnewswire·March 24, 2026 at 12:08 PM

/PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company developing autologous engineered neural tissue therapies, today announced a...

Original Source

Prnewswire — www.prnewswire.com

Related in Fintech

Worth raises $30M for SMB onboarding platform
PYMNTS
Spade Raises $40 Million for Transaction Data Analysis
PYMNTS
FTC Bans Air AI From Marketing Business Opportunities
PYMNTS
Braze Earnings Show AI Demand
PYMNTS

Matricelf (TASE: MTLF) Enters Strategic Collaboration with Sheba Medical Center to Advance First in Human Clinical Program in Spinal Cord Injury

Worth raises $30M for SMB onboarding platform

Spade Raises $40 Million for Transaction Data Analysis

FTC Bans Air AI From Marketing Business Opportunities

Braze Earnings Show AI Demand